Melanocytic lesions of the conjunctiva

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 12, 2010, Pages 1785-1792

  Zembowicz, Artur ^a   Mandal, Rajni V ^b   Choopong, Pitipol ^c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; CELL PROLIFERATION; CLASSIFICATION; CONJUNCTIVA TUMOR; HUMAN; MELANOCYTE; MELANOMA; MELANOSIS; METABOLISM; NEVUS; PATHOLOGY;

CELL PROLIFERATION; CONJUNCTIVAL NEOPLASMS; HUMANS; MELANOCYTES; MELANOMA; MELANOSIS; NEVUS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650437629     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Ash JE. Epibulbar tumors. Am J Ophthalmol. 1950;33:1203-1219.
2. Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004;111(9):1747-1754.
3. Damato B, Coupland SE. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol. 2008;36(8):786-795.
4. Ackerman AB, Sood R, Koenig M. Primary acquired melanosis of the conjunctiva is melanoma in situ [comment in Mod Pathol. 1992;5(4):473].
5. Mod Pathol. 1991;4(2):253-263.
6. Folberg R, Jakobiec FA, McLean IW, Zimmerman LE. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ?. Mod Pathol. 1992;5(1):2-5.
7. Zimmerman LE, Sobin LH. Histologic typing of tumors of the eye and its adnexa. In: International Histologic Classificasion of Tumors. Geneva, Zurich: World Health Organization; 1980:23-24.
8. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985;16(2):129-135.
9. Sugiura M, Colby KA, Mihm MC Jr, Zembowicz A. Low-risk and highrisk histologic features in conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29 cases. Am J Surg Pathol. 2007;31(2):185-192.
10. Shields JA, Shields CL, Mashayekhi A, et al. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes-the 2006 Lorenz. Zimmerman lecture. Ophthalmology. 2008;115(3):511-519.
11. Shields CL, Fasiuddin AF, Mashayekhi A, et al. Conjunctival nevi: clinical features and natural course in 410 consecutive patients [erratum in Arch Ophthalmol. 2006;124(2):198].
12. Arch Ophthalmol. 2004;122(2):167-175.
13. Liesegang TJ. Pigmented conjunctival and scleral lesions. Mayo Clin Proc. 1994;69(2):151-161.
14. Farber M, Schutzer P, Mihm MC. Pigmented lesions of the conjunctiva [comment in J Am Acad Dermatol. 2000;42(1, pt 1):145].
15. J Am Acad Dermatol. 1998;38(6, pt 1):971-978.
16. Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T. Benign conjunctival melanocytic lesions: clinicopathologic features. Ophthalmology. 1989;96(4):436-641.
17. Grin JM, Grant-Kels JM, Grin CM, Berke A, Kels BD. Ocular melanomas and melanocytic lesions of the eye [comment in J Am Acad Dermatol. 2000;42(1, pt 1):145].
18. J Am Acad Dermatol. 1998;38(5, pt 1):716-730.
19. Zamir E, Mechoulam H, Micera A, et al. Inflamed juvenile conjunctival naevus: clinicopathological characterisation. Br J Ophthalmol. 2002;86(1):28-30.
20. Thiagalingam S, Johnson MM, Colby KA, Zembowicz A. Juvenile conjunctival nevus: clinicopathologic analysis of 33 cases. Am J Surg Pathol. 2008;32(3):399-406.
21. Kabukcuoglu S, McNutt NS. Conjunctival melanocytic nevi of childhood. J Cutan Pathol. 1999;26(5):248-252.
22. Crawford JB, Howes ELJ, Char DH. Combined nevi of the conjunctiva. Arch Ophthalmol. 1999;117(9):1121-1127.
23. Farber M, Schutzer P, Mihm MC. Pigmented lesions of the conjunctiva. J Dermatol. 1996;23(11):746-750.
24. Seregard S. Pigmented spindle cell naevus of reed presenting in the conjunctiva. Acta Ophthalmol Scand. 2000;78(1):104-106.
25. Kantelip B, Boccard R, Nores JM, Bacin F. A case of conjunctival Spitz nevus: review of literature and comparison with cutaneous locations. Ann Ophthalmol. 1989;21(5):176-179.
26. Vervaet N, Van Ginderdeuren R, van den Oord JJ, Foets B. A rare conjunctival Spitz nevus: a case report and literature review. Bull Soc Belge Ophtalmol. 2007; (303):63-67.
27. Blicker JA, Rootman J, White VA. Cellular blue nevus of the conjunctiva. Ophthalmology. 1992:99 (11):1714-1717.
28. Jao W, Fretzin DF, Sundaran L, et al. Balloon cell nevus of the conjunctiva. Arch Pathol Lab Med. 1973;96(2):124-126.
29. Pfaffenbach DD, Green WR, Maumenee AE, Pfaffenbach DD, Green WR, Maumenee AE. Balloon cell nevus of the conjunctiva. Arch Ophthalmol. 1972;87(2):192-195.
30. Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T. Benign conjunctival melanocytic lesions: clinicopathologic features. Ophthalmology. 1989;96(4):436-461.
31. Seregard S, af TE, Mansson-Brahme E, Kock E, Bergenmar M, Ringborg U. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome: a case-control study. Ophthalmology. 1995;102(10):1524-1529.
32. Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol. 1986;17(7):652-654.
33. Shields JA, Shields CL, Mashayekhi A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Trans Am Ophthalmol Soc. 2007;105:61-71.
34. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990;74(10):615-619.
35. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol. 1996;234(9):569-572.
36. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol (Copenh). 1992;70(3):289-296.
37. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol. 1985;16(2):136-143.
38. Missotten GS, Keijser S, de Keizer RJ, et al. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci. 2005;46(1):75-82.
39. Tuomaala S, Eskelin S, Tarkkanen A, Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43(11):3399-3408.
40. Tuomaala S, Kivelä T. Conjunctival melanoma: is it increasing in the United States? [comment]. Am J Ophthalmol. 2003 December; 136(6):1189-1190.
41. Inskip PD, Devesa SS, Fraumeni JF Jr. Trends in the incidence of ocular melanoma in the United States, 1974-1998 [comment in Cancer Causes Control. 2004;15(1):95-96].
42. Cancer Causes Control. 2003;14(3):251-257.
43. Yu GP, Hu DN, McCormick S, et al. Conjunctival melanoma: is it increasing in the United States? [comment in Am J Ophthalmol. 2003;136(6):1189-1190].
44. Am J Ophthalmol. 2003 June; 135(6):800-806.
45. Taban M, Traboulsi EI, Taban M, Traboulsi EI. Malignant melanoma of the conjunctiva in children: a review of the international literature 1965-2006. J Pediatr Ophthalmol Strabismus. 2007;44(5):277-282.
46. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients [comment]. Arch Ophthalmol. 2000;118(11):1497-1507.
47. Shields CL. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc. 2000;98:471-492.
48. Paridaens AD, McCartney AC, Minassian DC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol. 1994;78(7):520-528.
49. Tuomaala S, Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy [comment in Ophthalmology. 2004;111(12):2317].
50. Ophthalmology. 2004;111(4):816-821.
51. De Potter P, Shields CL, Shields JA, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol. 1993;77(10):624-630.
52. Tuomaala S, Aine E, Saari KM, Kivela T. Corneally displaced malignant conjunctival melanomas. Ophthalmology. 2002;109(5):914-919.
53. Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol. 2002;13(5):317-323.
54. Folberg R. Tumor progression in ocular melanomas. J Invest Dermatol. 1993;100(3):326S-331S.
55. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994;78(4):252-259.
56. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol. 2002;86(2):163-167.
57. Anastassiou G, Esser M, Bader E, et al. Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanoma. Melanoma Res. 2004;14(5):381-385.
58. Tuomaala S, Toivonen P, Al Jamal R, et al. Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res. 2007;32(11):939-952.
59. Bobic-Radovanovic A, Latkovic Z, Marinkovic J, Radovanovic Z. Predictors of survival in malignant melanoma of the conjunctiva: a clinicopathological and follow-up study. Eur J Ophthalmol. 1998;8(1):4-7.
60. McLean IW, Burner MN, Zimmerman LE, Jakobiec. Tumors of the Eye and Ocular Adnexa. Washington DC: Armed Forces Institute of Pathology; 1995. Atlas of Tumor Pathology; 13th series, vol. 5.
61. Liesegang TJ, Campbell RJ. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol. 1980;98(8):1385-1389.
62. Keijser S, Missotten GS, Bonfrer JM, et al. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions. Br J Ophthalmol. 2006;90(2):213-217.
63. Sharara NA, Alexander RA, Luthert PJ, Hungerford JL, Cree IA. Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology. 2001;39(4):426-431.
64. Spendlove HE, Damato BE, Humphreys J, Barker KT, Hiscott PS, Houlston RS. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res. 2004;14(6):449-452.
65. Gear H, Williams H, Kemp EG, Roberts F. BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci. 2004;45(8):2484-2488.
66. El Shabrawi Y, Radner H, Muellner K, Langmann G, Hoefler G. The role of UV-radiation in the development of conjunctival malignant melanoma. Acta Ophthalmol Scand. 1999;77(1):31-32.
67. Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008;14(21):6821-6828.
68. McCarthy JM, Rootman J, Horsman D, White VA. Conjunctival and uveal melanoma in the dysplastic nevus syndrome. Surv Ophthalmol. 1993;37(5):377-386.
69. Kurli M, Finger PT, Kurli M, Finger PT. Melanocytic conjunctival tumors. Ophthalmol Clin North Am. 2005;18(1):15-24.
70. Kurli M, Finger PT, Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108-1114.
71. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors: the 1994 Lynn. McMahan Lecture [comment in Arch Ophthalmol. 1999;117(8):1098-1099].
72. Arch Ophthalmol. 1997;115(6):808-815.